Is a complete FRA/328 research report available?

No complete published report is available for fra/328 (FRA/328) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/328 (FRA/328)

Frankfurt Stock Exchange: FRA/328 · EUR

€10.2

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/328 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	945.6M
Revenue (ttm)	69.2M
Net income (ttm)	-104.5M
EPS (ttm)	-€1.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.2M
Net income (ttm): -104.5M
EPS (ttm): -€1.29
Market cap: 945.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All FRA/328 indicators

Market & fundamental data

Available fields

162

Groups with data

Currency

USD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	409
Employees Change	22%
Employees Change Percent	5.77
Enterprise value	EUR 959.6M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 945.6M
Price	EUR 10.2
Price currency	EUR
Rev Per Employee	169,129.86x
Sic	2836
Symbol	fra/328
Website	https://www.meiragtx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.06%
EV/FCF	316.59x
EV/Sales	13.69x
FCF yield	0.32%
P/B ratio	-18.76x
P/S ratio	13.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-131.89%
EBITDA Margin	-116.25%
FCF margin	4.38%
Gross margin	95.41%
Gross Profit	EUR 66M
Gross Profit Growth	714.81%
Gross Profit Growth Q	-82.66%
Gross Profit Growth3 Y	77.44%
Gross Profit Growth5 Y	36.69%
Net Income	EUR -104.5M
Pretax Margin	-151.12%
Profit Margin	-151.12%
Profit Per Employee	EUR -255,595
ROA	-28.06
Roa5y	-24.56
ROCE	-153.5
Roe5y	-140.1
ROIC	-91.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	43.7%
Cagr3y	23.23%
Cagr5y	-2.71%
Revenue Growth	131.13x
Revenue Growth Q	-84.79x
Revenue Growth3 Y	80.24x
Revenue Growth5 Y	37.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.34
Assets	EUR 212.2M
Cash	EUR 62M
Current Assets	EUR 83.4M
Current Liabilities	EUR 152.7M
Debt	EUR 75.9M
Debt FCF	EUR 25.05
Equity	EUR -50.4M
Interest Coverage	-8.76
Liabilities	EUR 262.6M
Long Term Assets	EUR 128.8M
Long Term Liabilities	EUR 109.9M
Net Cash	EUR -13.9M
Net Cash By Market Cap	EUR -1.47
Net Debt FCF	EUR 4.58
Tangible Book Value	EUR -50.8M
Tangible Book Value Per Share	EUR -0.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.55
Net Working Capital	EUR -107.8M
Quick ratio	0.51
Working Capital	EUR -69.3M
Working Capital Turnover	EUR -2.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	43.66%
200-day SMA	7.7
3Y total return	87.16%
50-day SMA	9.76
50-day SMA vs 200-day SMA	50over200
5Y total return	-12.82%
All Time High	20.6
All Time High Change	-50.49%
All Time High Date	2021-12-30
All Time Low	3.26
All Time Low Change	212.88%
All Time Low Date	2023-10-25
ATR	0.33
Ch YTD	55.73
High	10.2
High52	12.5
High52 Date	2026-07-08
High52ch	-18.4%
Low	10.2
Low52	5.85
Low52 Date	2026-03-09
Low52ch	74.36%
Ma50ch	4.54%
Price vs 200-day SMA	32.43%
RSI	45.8
RSI Monthly	65.31
RSI Weekly	61.09
Sharpe ratio	0.81x
Sortino ratio	1.38
Total Return	-10.11%
Tr YTD	55.73
Tr1m	2%
Tr1w	-5.56%
Tr3m	32.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -91.2M
Operating margin	-131.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,350,297%
Net Borrowing	-37,277.5
Shares Insiders	3.75%
Shares Institutions	34.7%
Shares Qo Q	0.21%
Shares Yo Y	10.11%
Short Ratio	4.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -15.1M
Adjusted OCF	-10,921,909
Average Volume	5.7x
Bv Per Share	-0.62
CAPEX	EUR -4.1M
Ch1m	2
Ch1w	-5.56
Ch1y	43.66
Ch3m	32.47
Ch3y	87.16
Ch5y	-12.82
Ch6m	55.73
Change	0%
Change From Open	0
Close	10.2
Days Gap	0
Depreciation Amortization	10,809,600.5
Earnings Date	2026-08-14
EBIT	EUR -91.2M
EBITDA	EUR -80.4M
EPS	EUR -1.29
F Score	5
FCF	EUR 3M
FCF EV Yield	0.32x
Financing CF	386,816
Fiscal Year End	December
Founded	2,015
Investing CF	-4,037,282
Is Primary Listing	0
Last Report Date	2026-03-31
Ma150	7.9
Ma150ch	29.1%
Ma20	11.16
Ma20ch	-8.56%
Net CF	4,464,860
Next Earnings Date	2026-08-14
Open	10.2
P FCF Ratio	312
P OCF Ratio	131.7
Ppne	119,225,498.7
Price Date	2026-07-30
Relative Volume	15.61x
Revenue	69,174,113x
SBC By Revenue	26.17x
Share Based Comp	18,102,286
Tr6m	55.73%
Z Score	-5.24

FRA/328 (FRA/328)

Coverage state: Market snapshot only — no published research

Generate the first FRA/328 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/328

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All FRA/328 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/328

Frequently asked questions